Q1 Earnings Reports Demonstrate American Cannabis Industry Is Rapidly Scaling

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.

Subscribe to receive our free weekly newsletter in your inbox each Sunday morning.


Earnings season for American cannabis companies is off to a fantastic start. We heard from some of the largest operators and ancillary companies this past week, and they all provided strong near-term results. While the revenue growth rates remain impressive, what is really capturing our attention is how much more efficient these companies have become, resulting in bottom-line growth that is far exceeding expectations.

With four of the leading MSOs and two of the leading ancillary companies that reported, here is how revenue, gross profit and SG&A changed in Q1 compared to a year ago along with the change in operating margin:

Curaleaf, which reported revenue ahead of the consensus of $253 million, saw cash SG&A grow at 75%, well below the revenue growth rate, helping the operating margin expand 1900 bps. Green Thumb Industries, which reported entirely organic revenue growth, also exceeded expectations of $187 million. It boosted its operating margin by 1900 bps as well, with most of the gain coming from substantially lower SG&A relative to revenue. Trulieve, which also beat expectations of $189 million, was the only company to see gross profit grow more slowly than revenue, which was due to its entry into Pennsylvania. Its gross margin and operating margin remain at the top of the industry.

Hydrofarm was able to expand gross profit substantially more than its revenue growth and saw cash operating expenses grow significantly slower. Its operating margin expanded by 570 bps. GrowGeneration slightly expanded its gross margin but benefitted from significantly slower growth in its operating expenses. The company breaks out corporate SG&A, which was up just 5%, from store operations, which grew 125%. Finally, Harvest had the most impressive swing, with gross margin expanding significantly as cash SG&A actually declined despite a doubling in sales. The operating margin expanded by 7160 bps.

The largest American cannabis companies delivered impressive results in Q1, demonstrating that they are rapidly scaling and improving profitability. We discussed last week that weakness in large Canadian LP stocks has been weighing on the American stocks, and the news this week from Aurora Cannabis and Tilray, who are struggling with the adult-use market in Canada, pushed their stocks even lower. The MSOs that reported last week generally fared better than the New Cannabis Ventures Global Cannabis Stock Index, which fell 8.2%. Harvest, of course, rallied on the acquisition announcement:

While cannabis stocks continued to correct last week, led by large Canadian LPs, we didn’t see anything in the reports of leading American companies that would suggest any sort of fundamental reasons for concern. We will still be getting reports from several MSOs over the balance of May, and there aren’t any reports from large LPs until Canopy Growth reports in early June. Continued reports of strong execution from MSOs in the absence of negative reports from the largest Canadian LPs could capture investor attention in the weeks ahead.

Vireo Health International, Inc. is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Today, Vireo is licensed to grow, process, and/or distribute cannabis in 8 markets and operates 16 dispensaries nationwide. The company is focused on Arizona, Maryland, Minnesota, New Mexico and New York, with 3 of the markets recently legalizing and the other 2 potentially doing so in the near future.

Get up to speed by visiting the Vireo Health Investor Dashboard that we maintain on their behalf as a client of New Cannabis Ventures. Click the blue Follow Company button in order to stay up to date with their progress.

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:

To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.

Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index and the Ancillary Cannabis Index.

View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$12.5M per quarter.

Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.

Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.


Alan & Joel

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter